SC 13D/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

(Rule 13d-101)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED

PURSUANT TO § 240.13d-2(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 8)*

Horizon Pharma, Inc.

(Name of Issuer)

Common Stock, $0.0001 par value per share

(Title of Class of Securities)

44047T109

(CUSIP Number)

Michael R. Murphy

Discovery Group I, LLC

191 North Wacker Drive

Suite 1685

Chicago, Illinois 60606

Telephone Number: (312) 265-9600

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

March 17, 2014

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. o

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No.  44047T109
	1.	Names of Reporting Persons. Discovery Equity Partners, L.P.
	2.	Check the Appropriate Box if a Member of a Group (See Instructions)
		(a)	o
		(b)	o
	3.	SEC Use Only
	4.	Source of Funds (See Instructions) WC
	5.	Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o
	6.	Citizenship or Place of Organization Illinois
Number of Shares Beneficially Owned by Each Reporting Person With		7.	Sole Voting Power None.
		8.	Shared Voting Power 3,252,626
		9.	Sole Dispositive Power None.
		10.	Shared Dispositive Power 3,252,626
	11.	Aggregate Amount Beneficially Owned by Each Reporting Person 3,252,626
	12.	Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)     o
	13.	Percent of Class Represented by Amount in Row (11) 4.8%
	14.	Type of Reporting Person (See Instructions) PN

CUSIP No.  44047T109
	1.	Names of Reporting Persons. Discovery Group I, LLC
	2.	Check the Appropriate Box if a Member of a Group (See Instructions)
		(a)	o
		(b)	o
	3.	SEC Use Only
	4.	Source of Funds (See Instructions) AF
	5.	Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o
	6.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With		7.	Sole Voting Power None.
		8.	Shared Voting Power 3,252,626
		9.	Sole Dispositive Power None.
		10.	Shared Dispositive Power 3,252,626
	11.	Aggregate Amount Beneficially Owned by Each Reporting Person 3,252,626
	12.	Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)     o
	13.	Percent of Class Represented by Amount in Row (11) 4.8%
	14.	Type of Reporting Person (See Instructions) IA

CUSIP No.  44047T109
	1.	Names of Reporting Persons. Daniel J. Donoghue
	2.	Check the Appropriate Box if a Member of a Group (See Instructions)
		(a)	o
		(b)	o
	3.	SEC Use Only
	4.	Source of Funds (See Instructions) AF
	5.	Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o
	6.	Citizenship or Place of Organization United States of America
Number of Shares Beneficially Owned by Each Reporting Person With		7.	Sole Voting Power None.
		8.	Shared Voting Power 3,252,626
		9.	Sole Dispositive Power None.
		10.	Shared Dispositive Power 3,252,626
	11.	Aggregate Amount Beneficially Owned by Each Reporting Person 3,252,626
	12.	Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)     o
	13.	Percent of Class Represented by Amount in Row (11) 4.8%
	14.	Type of Reporting Person (See Instructions) IN

CUSIP No.  44047T109
	1.	Names of Reporting Persons. Michael R. Murphy
	2.	Check the Appropriate Box if a Member of a Group (See Instructions)
		(a)	o
		(b)	o
	3.	SEC Use Only
	4.	Source of Funds (See Instructions) AF
	5.	Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o
	6.	Citizenship or Place of Organization United States of America
Number of Shares Beneficially Owned by Each Reporting Person With		7.	Sole Voting Power None.
		8.	Shared Voting Power 3,252,626
		9.	Sole Dispositive Power None.
		10.	Shared Dispositive Power 3,252,626
	11.	Aggregate Amount Beneficially Owned by Each Reporting Person 3,252,626
	12.	Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)     o
	13.	Percent of Class Represented by Amount in Row (11) 4.8%
	14.	Type of Reporting Person (See Instructions) IN

Item 1.	Security and Issuer
	This Amendment No. 8 to Schedule 13D (“Amendment No. 8”) relates to the Common Stock, $0.0001 par value per share (the “Common Stock”), of Horizon Pharma, Inc., a Delaware corporation (the “Company”), which has its principal executive offices at 520 Lake Cook Road, Suite 520, Deerfield, Illinois 60015.  This Amendment No. 8 amends and supplements, as set forth below, the information contained in items 1, 3, 5 and 6 of the Schedule 13D filed by the Reporting Persons with respect to the Company on August 13, 2012, as amended by Amendment No. 1 thereto filed by the Reporting Persons with respect to the Company on October 25, 2012, as amended by Amendment No. 2 thereto filed by the Reporting Persons with respect to the Company on April 15, 2013, as amended by Amendment No. 3 thereto filed by the Reporting Persons with respect to the Company on May 14, 2013, as amended by Amendment No. 4 thereto filed by the Reporting Persons with respect to the Company on December 13, 2013, as amended by Amendment No. 5 thereto filed by the Reporting Persons with respect to the Company on January 17, 2014, as amended by Amendment No. 6 thereto filed by the Reporting Persons with respect to the Company on February 7, 2014 and as amended by Amendment No. 7 thereto filed by the Reporting Persons with respect to the Company on March 3, 2014 (as so amended, the “Schedule 13D”).  All capitalized terms used herein but not defined herein have the meanings set forth in the Schedule 13D.  Except as amended by this Amendment No. 8, all information contained in the Schedule 13D is, after reasonable inquiry and to the best of the Reporting Persons’ knowledge and belief, complete and correct as of the date of this Amendment No. 8.
Item 3.	Source and Amount of Funds or Other Consideration
	Item 3 of the Schedule 13D is hereby amended to read in its entirety as follows: The total purchase price for the 3,252,626 shares of Common Stock beneficially owned by the Reporting Persons as of March 18, 2014 was approximately $8,103,226.  The source of such funds was the assets of Discovery Equity Partners, including proceeds of margin loans under margin loan facilities maintained in the ordinary course of business by Discovery Equity Partners with a broker on customary terms and conditions.  Discovery Equity Partners is the legal owner of all of the Common Stock beneficially owned by Discovery Group and Messrs. Donoghue and Murphy.
Item 5.	Interest in Securities of the Issuer
	Item 5 of the Schedule 13D is hereby amended to read in its entirety as follows: The information concerning percentages of ownership set forth below is based on 67,733,417 shares of Common Stock reported outstanding as of March 11, 2014 in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2013. Discovery Equity Partners beneficially owns 3,252,626 shares of Common Stock as of March 18, 2014, which represents 4.8% of the outstanding Common Stock. Discovery Group beneficially owns 3,252,626 shares of Common Stock as of March 18, 2014, which represents 4.8% of the outstanding Common Stock. Mr. Donoghue beneficially owns 3,252,626 shares of Common Stock as of March 18, 2014, which represents 4.8% of the outstanding Common Stock. Mr. Murphy beneficially owns 3,252,626 shares of Common Stock as of March 18, 2014, which represents 4.8% of the outstanding Common Stock.

	Discovery Group is the sole general partner of Discovery Equity Partners.  Messrs. Donoghue and Murphy are the sole managing members of Discovery Group.  As a consequence, Discovery Group and Messrs. Donoghue and Murphy may be deemed to share beneficial ownership of all of the shares of Common Stock owned by Discovery Equity Partners. The transactions in Common Stock effected by the Reporting Persons during the past 60 days are set out in Exhibit 1 hereto. The Reporting Persons ceased to be beneficial owners of more than five percent of the Common Stock on March 17, 2014. No person other than Discovery Equity Partners is known to any Reporting Person to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, any of the shares of Common Stock reported herein.
Item 6.	Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer
	Item 6 of the Schedule 13D is hereby amended to read in its entirety as follows: There are no contracts, arrangements, understandings or relationships (legal or otherwise) between or among any of the Reporting Persons and any other person with respect to any securities of the Company other than the governing documents of Discovery Group and Discovery Equity Partners, the margin loan facilities referred to under Item 3 above, the Joint Filing Agreement of the Reporting Persons with respect to the Schedule 13D that were included as exhibits thereto, the Joint Filing Agreement of the Reporting Persons with respect to this Amendment No. 8 included asExhibit 2 to this Amendment No. 8, and the Powers of Attorney granted by Messrs. Donoghue and Murphy with respect to reports under Section 13 of the Securities Exchange Act of 1934, as amended, which Powers of Attorney are included asExhibit 3andExhibit 4, respectively, to this Amendment No. 8.

Item 7.	Material to Be Filed as Exhibits
	Exhibit 1: List of transactions effected by the Reporting Persons in the Company’s Common Stock during the 60-day period preceding this filing.
	Exhibit 2: Joint Filing Agreement dated as of March 19, 2014, by and among Discovery Equity Partners; Discovery Group; Daniel J. Donoghue; and Michael R. Murphy.
	Exhibit 3: Power of Attorney of Daniel J. Donoghue, dated as of April 28, 2008.
	Exhibit 4: Power of Attorney of Michael R. Murphy, dated as of April 28, 2008.

Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

March 19, 2014

Date

DISCOVERY GROUP I, LLC,

for itself and as general partner of

DISCOVERY EQUITY PARTNERS, L.P.

By:  Michael R. Murphy*

Signature

Michael R. Murphy, Managing Member

Name/Title

Daniel J. Donoghue*

Signature

Daniel J. Donoghue

Name/Title

Michael R. Murphy*

Signature

Michael R. Murphy

Name/Title

*By: /s/ Mark Buckley

Mark Buckley

Attorney-in-Fact for Daniel J. Donoghue

Attorney-in-Fact for Michael R. Murphy

Exhibit Index

Exhibit 1	List of transactions effected by the Reporting Persons in the Company’s Common Stock during the 60-day period preceding this filing.
Exhibit 2	Joint Filing Agreement dated as of March 19, 2014, by and among Discovery Equity Partners; Discovery Group; Daniel J. Donoghue; and Michael R. Murphy.
Exhibit 3	Power of Attorney of Daniel J. Donoghue, dated as of April 28, 2008.
Exhibit 4	Power of Attorney of Michael R. Murphy, dated as of April 28, 2008.

EX-1

EXHIBIT 1

TRANSACTIONS DURING PAST 60 DAYS

The Reporting Persons engaged in the following transactions in shares of Common Stock of the Company during the past 60 days.  Such transactions involved the purchase and sale of shares on the NASDAQ Global Market.  Certain of the prices reported below reflect the weighted average purchase or sale price of the shares of Common Stock purchased or sold on the relevant date.  The Reporting Persons hereby undertake to provide upon request to the SEC staff full information regarding the number of shares and prices at which each transaction was effected.

Date	Type	Price			Shares
1/21/2014	Sale	$	8.4269	1	50060
1/22/2014	Sale	$	8.3472	2	20000
1/23/2014	Sale	$	8.3304	3	32000
1/24/2014	Sale	$	8.4208	4	26600
1/27/2014	Sale	$	8.1957	5	7000
1/28/2014	Sale	$	8.3835	6	59699
1/29/2014	Sale	$	8.5300		1000
1/29/2014	Sale	$	9.6572	7	54000
1/29/2014	Sale	$	10.1776	8	21500
1/30/2014	Sale	$	10.0961	9	60115
1/31/2014	Sale	$	9.8592	10	73301
2/3/2014	Sale	$	9.9855	11	75000
2/4/2014	Sale	$	9.9349	12	41500
2/5/2014	Sale	$	9.9428	13	59966
2/6/2014	Sale	$	9.8388	14	29128
2/7/2014	Sale	$	9.9059	15	22000
2/10/2014	Sale	$	10.0934	16	28380
2/11/2014	Sale	$	10.0462	17	34119
2/12/2014	Sale	$	9.9373	18	13420
2/13/2014	Sale	$	10.2923	19	65746
2/14/2014	Sale	$	10.2262	20	41000
2/18/2014	Sale	$	10.7295	21	69500
2/19/2014	Sale	$	11.0038	22	60947
2/20/2014	Sale	$	11.1349	23	56100
2/21/2014	Sale	$	11.9801	24	81376
2/24/2014	Sale	$	12.1611	25	78100
2/25/2014	Sale	$	12.0987	26	30000
2/26/2014	Sale	$	12.1875	27	33044
2/27/2014	Sale	$	12.5163	28	106600
2/28/2014	Sale	$	12.5744	29	8800
3/3/2014	Sale	$	12.5385	30	107790
3/4/2014	Purchase	$	13.0800		1000
3/4/2014	Sale	$	13.0821	31	72074
3/5/2014	Sale	$	13.3917	32	75825
3/6/2014	Sale	$	13.0437	33	86246
3/7/2014	Sale	$	13.1354	34	44000
3/10/2014	Sale	$	13.4804	35	69700
3/11/2014	Sale	$	13.7544	36	60898
3/12/2014	Sale	$	13.4527	37	87100
3/13/2014	Sale	$	13.1912	38	3195
3/17/2014	Sale	$	13.9288	39	185825
3/18/2014	Sale	$	14.4440	40	130630

1 This transaction was executed in multiple trades at prices ranging from $8.27 – 8.82. 

2 This transaction was executed in multiple trades at prices ranging from $8.24 – 8.47.

3 This transaction was executed in multiple trades at prices ranging from $8.19 – 8.47.

4 This transaction was executed in multiple trades at prices ranging from $8.34 – 8.53. 

5 This transaction was executed in multiple trades at prices ranging from $8.17 – 8.21. 

6 This transaction was executed in multiple trades at prices ranging from $8.19 – 8.5050. 

7 This transaction was executed in multiple trades at prices ranging from $9.05 – 10.05. 

8 This transaction was executed in multiple trades at prices ranging from $10.07 – 10.48. 

9 This transaction was executed in multiple trades at prices ranging from $9.89 – 10.50. 

10 This transaction was executed in multiple trades at prices ranging from $9.70 – 10.00. 

11 This transaction was executed in multiple trades at prices ranging from $9.68 – 10.15. 

12 This transaction was executed in multiple trades at prices ranging from $9.65 – 10.26. 

13 This transaction was executed in multiple trades at prices ranging from $9.77 – 10.00. 

14 This transaction was executed in multiple trades at prices ranging from $9.76 – 10.04. 

15 This transaction was executed in multiple trades at prices ranging from $9.78 – 10.05. 

16 This transaction was executed in multiple trades at prices ranging from $10.04 – 10.15. 

17 This transaction was executed in multiple trades at prices ranging from $9.90 – 10.12. 

18 This transaction was executed in multiple trades at prices ranging from $9.90 – 9.96. 

19 This transaction was executed in multiple trades at prices ranging from $9.90 – 10.60. 

20 This transaction was executed in multiple trades at prices ranging from $10.00 – 10.32. 

21 This transaction was executed in multiple trades at prices ranging from $10.24 – 11.06. 

22 This transaction was executed in multiple trades at prices ranging from $10.80 – 11.14. 

23 This transaction was executed in multiple trades at prices ranging from $11.00 – 11.25. 

24 This transaction was executed in multiple trades at prices ranging from $11.60 – 12.24. 

25 This transaction was executed in multiple trades at prices ranging from $11.66 – 12.37. 

26 This transaction was executed in multiple trades at prices ranging from $11.99 – 12.26. 

27 This transaction was executed in multiple trades at prices ranging from $11.94 – 12.36. 

28 This transaction was executed in multiple trades at prices ranging from $12.09 – 12.74. 

29 This transaction was executed in multiple trades at prices ranging from $12.45 – 12.84. 

30 This transaction was executed in multiple trades at prices ranging from $12.30 – 12.85. 

31 This transaction was executed in multiple trades at prices ranging from $12.98 – 13.35. 

32 This transaction was executed in multiple trades at prices ranging from $13.00 – 13.59. 

33 This transaction was executed in multiple trades at prices ranging from $12.77 – 13.15. 

34 This transaction was executed in multiple trades at prices ranging from $12.90 – 13.25. 

35 This transaction was executed in multiple trades at prices ranging from $13.19 – 13.64. 

36 This transaction was executed in multiple trades at prices ranging from $13.30 – 14.25. 

37 This transaction was executed in multiple trades at prices ranging from $13.15 – 13.69. 

38 This transaction was executed in multiple trades at prices ranging from $13.18 – 13.20. 

39 This transaction was executed in multiple trades at prices ranging from $13.56 – 14.12. 

40 This transaction was executed in multiple trades at prices ranging from $14.08 – 14.75.

EX-2

EXHIBIT 2

JOINT FILING AGREEMENT

The undersigned hereby agree to the joint filing of the Amendment No. 8 to Schedule 13D to which this Agreement is attached.

Dated: March 19, 2014

DISCOVERY GROUP I, LLC for itself and as general partner of DISCOVERY EQUITY PARTNERS, L.P.
By	Michael R. Murphy*
	Michael R. Murphy
	Managing Member
Daniel J. Donoghue*
Daniel J. Donoghue
Michael R. Murphy*
Michael R. Murphy

*By:	/s/ Mark Buckley
	Mark Buckley
	Attorney-in-Fact for Daniel J. Donoghue
	Attorney-in-Fact for Michael R. Murphy

EX-3

EXHIBIT 3

POWER OF ATTORNEY

The undersigned, Daniel J. Donoghue, hereby appoints Mark Buckley his true and lawful attorney-in-fact and agent, with full power to execute and file with the United States Securities and Exchange Commission and any stock exchange or similar authority, for and on his behalf in any and all capacities, any and all reports required to be filed pursuant to Section 13 of the Securities Exchange Act of 1934 and the rules thereunder on Schedule 13D or 13G, any and all amendments to such reports, with all exhibits, and any other forms or documents as may be necessary in connection with the filing of such reports with the United States Securities and Exchange Commission and any stock exchange or similar authority, granting unto said attorney full power and authority to do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete, as fully as the undersigned might or could do in person.

This Power of Attorney shall remain in full force and effect until revoked by the undersigned in a signed writing delivered to the foregoing attorney-in-fact and agent.

IN WITNESS WHEREOF the undersigned has caused this Power of Attorney to be executed this 28th day of April, 2008.

/s/ Daniel J. Donoghue

Daniel J. Donoghue

STATE OF ILLINOIS	)
	) SS.
COUNTY OF COOK	)

I, Kareema M. Cruz, a Notary Public in and for the County of Cook, State of Illinois, DO HEREBY CERTIFY that Daniel J. Donoghue, who is personally known to me to be the same person whose name is subscribed to the foregoing instrument, appeared before me this day in person and acknowledged that he signed and delivered the said instrument as his own free and voluntary act, for the uses and purposes therein set forth.

Given under my hand and notarial seal, this 28th day of April, 2008.

/s/ Kareema M. Cruz

Notary Public

EX-4

EXHIBIT 4

POWER OF ATTORNEY

The undersigned, Michael R. Murphy, hereby appoints Mark Buckley his true and lawful attorney-in-fact and agent, with full power to execute and file with the United States Securities and Exchange Commission and any stock exchange or similar authority, for and on his behalf in any and all capacities, any and all reports required to be filed pursuant to Section 13 of the Securities Exchange Act of 1934 and the rules thereunder on Schedule 13D or 13G, any and all amendments to such reports, with all exhibits, and any other forms or documents as may be necessary in connection with the filing of such reports with the United States Securities and Exchange Commission and any stock exchange or similar authority, granting unto said attorney full power and authority to do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete, as fully as the undersigned might or could do in person.

This Power of Attorney shall remain in full force and effect until revoked by the undersigned in a signed writing delivered to the foregoing attorney-in-fact and agent.

IN WITNESS WHEREOF the undersigned has caused this Power of Attorney to be executed this 28th day of April, 2008.

/s/ Michael R. Murphy

Michael R. Murphy

STATE OF ILLINOIS	)
	) SS.
COUNTY OF COOK	)

I, Kareema M. Cruz, a Notary Public in and for the County of Cook, State of Illinois, DO HEREBY CERTIFY that Michael R. Murphy, who is personally known to me to be the same person whose name is subscribed to the foregoing instrument, appeared before me this day in person and acknowledged that he signed and delivered the said instrument as his own free and voluntary act, for the uses and purposes therein set forth.

Given under my hand and notarial seal, this 28th day of April, 2008.

/s/ Kareema M. Cruz

Notary Public